Stéphanie Monlezun

1 Patent

• US125838842026

  3beta-(benzyloxy)-17alpha-methyl-pregn-5-en-20-one for Use in the Treatment of Cognitive Disorders

  UNIVERSITE DE BORDEAUX

  0 cites